Macrogenics (MGNX) Share-based Compensation (QoQ) (2012 - 2026)
Macrogenics (MGNX) Share-based Compensation (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Macrogenics | 268.22 Mn | 201.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.34% |
| Dec 31, 2025 | -199.95% |
| Sep 30, 2025 | 376.39% |
| Jun 30, 2025 | -193.57% |
| Mar 31, 2025 | -61.07% |
| Dec 31, 2024 | 88.69% |
| Sep 30, 2024 | -39.16% |
| Jun 30, 2024 | 310.41% |
| Mar 31, 2024 | -45.15% |
| Dec 31, 2023 | -9.00% |
| Sep 30, 2023 | -47.17% |
| Jun 30, 2023 | 5,637.97% |
| Mar 31, 2023 | -96.67% |
| Dec 31, 2022 | -69.80% |
| Dec 31, 2021 | 320.19% |
| Sep 30, 2021 | -261.33% |
| Jun 30, 2021 | 14.83% |
| Mar 31, 2021 | 0.55% |
| Dec 31, 2020 | -9.86% |
| Sep 30, 2020 | 14.44% |